Morning trading November 26, page-2

AYA - Artrya IPO lists at 12:30pm.


Washington H. Soul Pattinson is an investor in this company. Spread was offered to non-institutional investors. The rest of the stock went to the big boys at the top of the food chain.

Artrya (https://www.artrya.com) has already received considerable private and government support – securing $19 million over the last two years to develop, test and commercialise its Salix software which detects and assesses the presence of vulnerable plaque in patient’s arteries.

Artrya’s technology, called Salix, analyses cardiac CT scans in minutes and produces a 3D image and report that provides a more accurate detection of coronary artery disease, including the presence of vulnerable plaque, which is challenging to identify with existing technology.

It can also show the movement of blood through the heart, called a fractional flow reserve. Traditionally fractional flow reserve is measured via coronary angiogram – a minimally invasive procedure in which contrast dye and x-ray imaging is used to detect blockages in the arteries.